Intech Investment Management LLC Sells 18,317 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Intech Investment Management LLC trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 12.1% during the fourth quarter, Holdings Channel reports. The firm owned 133,453 shares of the company’s stock after selling 18,317 shares during the quarter. Intech Investment Management LLC’s holdings in Henry Schein were worth $10,104,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Henry Schein in the 4th quarter valued at about $39,000. Neo Ivy Capital Management bought a new stake in shares of Henry Schein in the 3rd quarter valued at about $46,000. Covestor Ltd raised its holdings in shares of Henry Schein by 22.8% in the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock valued at $102,000 after purchasing an additional 254 shares during the period. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Henry Schein by 37.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock valued at $114,000 after purchasing an additional 416 shares during the period. Finally, GAMMA Investing LLC bought a new stake in shares of Henry Schein in the 4th quarter valued at about $115,000. 96.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HSIC. Barrington Research upped their target price on shares of Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. Evercore ISI increased their price target on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Piper Sandler increased their price target on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. Finally, UBS Group lowered their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $81.73.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded up $0.20 on Friday, reaching $71.72. 458,504 shares of the company’s stock were exchanged, compared to its average volume of 1,089,650. The company has a fifty day moving average of $72.49 and a 200-day moving average of $72.96. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a market capitalization of $9.18 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 1.79 and a beta of 0.87. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter in the prior year, the business posted $1.21 EPS. The business’s revenue was up 3.7% compared to the same quarter last year. On average, research analysts predict that Henry Schein, Inc. will post 5.08 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.